Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate

被引：0
|
作者：
van Drunen, C
Meltzer, EO
Bachert, C
Bousquet, J
Fokkens, WJ
机构：
[1] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1100 DD Amsterdam, Netherlands
[2] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[3] Ghent Univ Hosp, ENT Dept, B-9000 Ghent, Belgium
[4] Cent Hosp Univ, Hop Arnaud de Villeneuve, Dept Resp Dis, Montpellier, France
来源：
ALLERGY | 2005年 / 60卷
关键词：
mometasone furoate; allergic rhinitis; nasal allergies; intranasal corticosteroids;
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Mometasone furoate nasal spray (MFNS; Nasonex(R), Schering-Plough Corporation, Kenilworth, NJ, USA) is an effective and well-tolerated intranasal corticosteroid approved for the prophylactic treatment of seasonal allergic rhinitis, and the treatment of perennial allergic rhinitis. MFNS is a potent molecule with a rapid onset of action and excellent safety and efficacy profiles. Having recently received approval for the treatment of nasal polyposis, data indicate that MFNS may also be effective in rhinosinusitis.
引用
收藏
页码：5 / 19
页数：15
相关论文
共 50 条
  • [31] Mometasone furoate nasal spray plus oxymetazoline nasal spray: Short-term efficacy and safety in seasonal allergic rhinitis
    Meltzer, Eli O.
    Bernstein, David I.
    Prenner, Bruce M.
    Berger, William E.
    Shekar, Tulin
    Teper, Ariel A.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2013, 27 (02) : 102 - 108
  • [32] Efficacy of Mometasone Furoate Nasal Spray in Relieving Congestion in Patients With Nasal Polyps With or Without Eosinophilia
    Small, C. B.
    Stryszak, P.
    Teper, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB44 - AB44
  • [33] Once-daily mometasone furoate nasal spray: Efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis
    Davies, RJ
    Nelson, HS
    CLINICAL THERAPEUTICS, 1997, 19 (01) : 27 - 38
  • [34] Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids
    Spada, Fabrizio
    Barnes, Tanya M.
    Greive, Kerryn A.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 (03) : E168 - E174
  • [35] Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate
    Nathan, RA
    Nayak, AS
    Graft, DF
    Lawrence, M
    Picone, FJ
    Ahmed, T
    Wolfe, J
    Vanderwalker, ML
    Nolop, KB
    Harrison, JE
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 86 (02) : 203 - 210
  • [36] Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis
    Anolik, Robert
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (03) : 264 - 271
  • [37] Efficacy and safety of long-term treatment of perennial allergic rhinitis with mometasone furoate nasal spray in japanese subjects
    Ishikawa, T.
    Soh, N.
    Oda, T.
    Jensen, P.
    ALLERGY, 2008, 63 : 362 - 362
  • [38] COMPARATIVE EFFICACY AND ACCEPTABILITY OF MOMETASONE FUROATE AND CICLESONIDE AQUEOUS NASAL SPRAY IN ALLERGIC RHINITIS
    Barik, Sadananda
    Gaur, S. N.
    Kumar, Raj
    RESPIROLOGY, 2010, 15 : 32 - 32
  • [39] CLINICAL AND ECONOMIC ANALYSIS OF MOMETASONE FUROATE NASAL SPRAY IN THE TREATMENT OF RHINOSINUSITIS IN MEXICO
    Rely, K.
    Blandon, V
    Fonseca, A.
    Canedo, A.
    Salinas, G. E.
    Alexandre, P. K.
    VALUE IN HEALTH, 2013, 16 (07) : A724 - A724
  • [40] Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children
    Brannan, MD
    Herron, JM
    Affrime, MB
    CLINICAL THERAPEUTICS, 1997, 19 (06) : 1330 - 1339
12345